- Home
- SFNC vs HCM Comparison
SFNC vs HCM Comparison
Compare SFNC & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SFNC
- HCM
- Stock Information
- Founded
- SFNC 1903
- HCM 2000
- Country
- SFNC United States
- HCM Hong Kong
- Employees
- SFNC N/A
- HCM N/A
- Industry
- SFNC Major Banks
- HCM Biotechnology: Pharmaceutical Preparations
- Sector
- SFNC Finance
- HCM Health Care
- Exchange
- SFNC Nasdaq
- HCM Nasdaq
- Market Cap
- SFNC 2.2B
- HCM 2.5B
- IPO Year
- SFNC N/A
- HCM N/A
- Fundamental
- Price
- SFNC $17.39
- HCM $13.76
- Analyst Decision
- SFNC Hold
- HCM Hold
- Analyst Count
- SFNC 3
- HCM 1
- Target Price
- SFNC $23.33
- HCM $19.00
- AVG Volume (30 Days)
- SFNC 868.7K
- HCM 128.4K
- Earning Date
- SFNC 04-16-2025
- HCM 03-19-2025
- Dividend Yield
- SFNC 4.89%
- HCM N/A
- EPS Growth
- SFNC N/A
- HCM N/A
- EPS
- SFNC 1.16
- HCM 0.04
- Revenue
- SFNC $726,747,000.00
- HCM $630,201,000.00
- Revenue This Year
- SFNC $21.32
- HCM $28.98
- Revenue Next Year
- SFNC $7.03
- HCM $20.41
- P/E Ratio
- SFNC $14.99
- HCM $63.68
- Revenue Growth
- SFNC N/A
- HCM N/A
- 52 Week Low
- SFNC $16.03
- HCM $11.51
- 52 Week High
- SFNC $25.95
- HCM $21.92
- Technical
- Relative Strength Index (RSI)
- SFNC 29.12
- HCM 46.20
- Support Level
- SFNC $17.35
- HCM $13.50
- Resistance Level
- SFNC $18.47
- HCM $15.11
- Average True Range (ATR)
- SFNC 0.89
- HCM 0.66
- MACD
- SFNC -0.10
- HCM -0.00
- Stochastic Oscillator
- SFNC 5.25
- HCM 45.69
About SFNC Simmons First National Corporation
Simmons First National Corp is a financial holding company. The company through its subsidiaries is engaged in providing banking services including consumer, real estate and commercial loans, checking, savings and time deposits. The company's loan portfolio comprises construction, single-family residential and commercial loans; non-real estate loans, nonaccrual and past due loans; and credit card loans, student loans and other consumer loans. It also offers various products and services such as trust services, investments, agricultural finance lending, equipment lending, insurance, consumer finance and small business administration lending. The business activity of the firm is functioned through the region of the United States.
About HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.